In addition, based on the fact that vitamin-like A enhances IFN-I and antiviral effects by activating RIG-I, RA has been proposed for inclusion in COVID-19 treatment regimens, especially in combination with type 1 interferon [29]. Here, RIGI is linked to COVID-19.